Roivant Sciences Ltd.
ROIV
$28.58
-$0.95-3.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 246.75% | -256.98% | 50.68% | -334.38% | -36.63% |
| Total Depreciation and Amortization | -92.19% | -64.44% | -51.91% | -46.41% | -40.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1,629.26% | 118.23% | -64.07% | 124.86% | -167.69% |
| Change in Net Operating Assets | -1,843.06% | 117.65% | -31.38% | 45.93% | 116.13% |
| Cash from Operations | 5.07% | 5.20% | 30.41% | -5.99% | -59.11% |
| Capital Expenditure | -55.49% | 370.11% | -687.95% | -318.13% | -132.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -105.90% | -- | -- | -- | 9,419.15% |
| Other Investing Activities | -82.08% | -65.32% | 103.77% | -- | 12,275.68% |
| Cash from Investing | -83.85% | -75.89% | 103.66% | -112,409.43% | 15,405.11% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 294.61% | 323.96% | 850.30% | 1,223.51% | 254.88% |
| Repurchase of Common Stock | 60.86% | 90.53% | 94.34% | 67.05% | -958.59% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -101.24% | -- | -- | -- | -- |
| Cash from Financing | 61.18% | 220.24% | 157.38% | 71.58% | -443.01% |
| Foreign Exchange rate Adjustments | 369.12% | 140.30% | -76.09% | 129.74% | 42.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.98% | 988.44% | 99.96% | -72.32% | 636.25% |